Marvin Rubenstein
Affiliations: | Rush University, Chicago, IL, United States |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Marvin Rubenstein"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rubenstein M, Hollowell CM, Guinan P. (2015) Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation. In Vivo (Athens, Greece). 29: 687-93 |
| Rubenstein M, Hollowell CMP, Guinan P. (2014) Additional compensatory mechanisms altering antisense oligonucleotide suppression of BCL2: Effects upon AKT1 and STAT3 In Vivo. 28: 867-870 |
| Anderson KM, Guinan P, Rubenstein M. (2014) Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells. Medical Oncology (Northwood, London, England). 31: 779 |
| Rubenstein M. (2014) Prostate Cancer Surface Antigenicity and the Interferon Induction Hypothesis in LNCaP Cells Treated with Antisense Oligonucleotides Cancer Science & Research: Open Access. 1: 1-7 |
| Guinan P, Ongbueco K, Rubenstein M. (2014) Ethnic belief differences in the incidence and mortality of prostate cancer. Journal of Clinical Oncology. 32: e16108-e16108 |
| Rubenstein M, Hollowell CMP, Guinan P. (2013) Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3 Medical Oncology. 30 |
| Rubenstein M, Hollowell CM, Guinan P. (2013) Increased expression of the androgen receptor with p300 and interleukin-6 coactivators compensate for oligonucleotide suppression of bcl-2: no increased CREB binding protein or interleukin-4 expression. Therapeutic Advances in Urology. 5: 85-93 |
| Rubenstein M, Hollowell CMP, Guinan P. (2013) No compensation in CD44 stem cell marker following BCL-2 suppression by antisense oligonucleotides In Vivo. 27: 251-256 |
| Guinan P, Rubenstein M, Hollowell CMP. (2013) Effect of suppression of bcl-2 with antisense oligonucleotides on p53 expression. Journal of Clinical Oncology. 31 |
| Rubenstein M, Hollowell CMP, Guinan P. (2013) Involvement of compensatory CD44+ stem cells following BCL-2 suppression by antisense oligonucleotides. Journal of Clinical Oncology. 31: 2590-2590 |